UBS has recently reduced P10 Inc (PX) stock to Neutral rating, as announced on August 21, 2024, according to Finviz. Earlier, on March 4, 2024, Morgan Stanley had reduced the stock rating, setting a price target of $9. for PX stock. Keefe Bruyette also reduced Mkt Perform rating with a price target of $10. Additionally, JP Morgan reduced Neutral rating on March 1, 2024, with a target price of $9.50. Barclays analysts, in their report published on August 31, 2022, also initiated Overweight rating for P10 Inc’s stock. Analyst ratings are significant because they provide insights into stock performance expectations, influencing investor decisions and market sentiment.
P10 Inc (PX) Stock Trading Recap
On Tuesday, P10 Inc (PX) stock saw a decline, ending the day at $9.96 which represents a decrease of $-0.09 or -0.90% from the prior close of $10.05. The stock opened at $9.99 and touched a low of $9.6 during the day, reaching a high of $9.99. The volume of shares traded was 0.67 million exceeding the average volume of 0.54 million.
Sponsored
PX Stock Performance and Moving Averages
In recent trading, P10 Inc (PX) stock price has shown some volatility, fluctuating -1.29% over the last five trades and 6.64% over the past 30 trades. This represents a notable shift from earlier in the year. Over the last six months, the stock has risen by 24.66%, and it has gained 24.03% in the previous three months. Currently, PX is trading at 2.63%, 6.04%, and 12.48% relative to its 20-Day, 50-Day, and 200-Day Simple Moving Averages, respectively.
As of the latest trading close, PX, a Financial sector stock, is trading -18.76% below its 52-week high but remains 40.68% above its 52-week low. The Average True Range (ATR) (14 days) of 0.33 highlights the stock’s average volatility, providing insight into how much the price typically fluctuates. This measure is crucial for understanding potential price swings and assessing overall market risk.
P10 Inc’s Profitability and Valuation Ratios
P10 Inc’s profitability metrics reveal strong financial health. The company currently boasts an operating margin of 14.31% and a profit margin of 0.97%, with a gross margin of 24.66%. The profit margin, also known as the revenue ratio or gross profit ratio, measures how efficiently a company converts sales into net income; higher margins indicate greater profitability.
In terms of valuation, P10 Inc’s market capitalization stands at $1.11 billion. Market cap represents the total value of all outstanding shares and is a key indicator of a company’s market value. The stock’s price-to-earnings (P/E) ratio is 575.72, assessing the company’s valuation relative to its earnings. The forward P/E ratio, which uses projected earnings for the next financial year, is 10.99. Additionally, the Price-to-Sales Ratio is 4.29, reflecting the market’s valuation of the company’s sales, while the Price-to-Book Ratio is 3.12, comparing the market value to the company’s book value.
Understanding Insider Trading
Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 63.72% of P10 Inc (PX)’s shares, while financial institutions hold 31.19%.
Notable insider trades include Abell Alexander I., at P10 Inc (PX), who sold 15621 shares on Jun 24 ’24, at $8.3 each, totaling $0.13 million. On Mar 25 ’24, Feinglass Michael, sold 50000 shares for $8.07 each, amounting to $0.40 million. Additionally, on Mar 20 ’24, Feinglass Michael sold 51730 shares at $8.17 each, generating $0.42 million.
